Alnylam Pharmaceuticals - Largest Companies by Marketcap, Revenue, Net Income and Employees

Top Corporates Hub

Alnylam Pharmaceuticals

ALNY | NASDAQ | United States
535
+37
Rank
$31.75B
Market Cap
$2.24B
+$ 0.42B
+23.08%
Revenue
$-0.24B
+$ 0.09B
-27.27%
Earnings
2.2K
+0.1K
+6.19%
Employees
Track all markets on TradingView

About

Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.



  • Sector: Health Technology
  • Industry: Pharmaceuticals: Major
  • Headquarters:

Latest News

More news